Il diritto alla conoscenza delle sperimentazioni cliniche ed il rischio d’ instabilità del mercato dei farmaci
The right to know clinical testing and the risk to destabilise the market of medications
Keywords:
Access to documents; Protection of commercial interests; Medicinal product for human use; Documents submitted to the European Medicines Agency; General presumption of confidentiality
Downloads
Published
2020-07-07
How to Cite
De Falco, V. (2020). Il diritto alla conoscenza delle sperimentazioni cliniche ed il rischio d’ instabilità del mercato dei farmaci: The right to know clinical testing and the risk to destabilise the market of medications. DPCE Online, 43(2). Retrieved from https://www.dpceonline.it/index.php/dpceonline/article/view/1018
Issue
Section
Note e Commenti
License
CC Attribution-NonCommercial-ShareAlike 4.0
